Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novacea and Schering-Plough sign license agreement for Asentar

June 1, 2007

Improved efficacy of PhGalpha1 demonstrated in new preclinical studies

June 1, 2007

Recent clinical trials in urological cancer

June 1, 2007

New therapeutic options for cancer imparted in recent patents

June 1, 2007

Torisel approved for advanced renal cell carcinoma

May 31, 2007

Protherics withdraws European application for Voraxaze

May 31, 2007

Archexin cleared to begin phase II trial in renal cell carcinoma

May 31, 2007

New phase II trial for Panzem NCD with Temodar in recurrent GBM

May 31, 2007

Genzyme to acquire Bioenvision

May 31, 2007

HyCAMP shows greater efficacy than Camptosar in metastatic colorectal cancer

May 31, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...